Nitric oxide: An emerging role in cardioprotection?

Heart

Volumn 86, Issue 4, 2001, Pages 368-372

  Rakhit, R D ^a   Marber, M S ^b  

^a ST MARY S HOSPITAL   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOACETIC ACID; ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID 3 (NITROXYMETHYL)PHENYL ESTER; ACETYLSALICYLIC ACID 4 NITROXYBUTYL ESTER; ADENOSINE; AMLODIPINE; ARGININE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GLYCERYL TRINITRATE; LINSIDOMINE; NEVIBOLOL; NICORANDIL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITROPRUSSIDE SODIUM; PRAVASTATIN; SILDENAFIL; THIOL DERIVATIVE; UNCLASSIFIED DRUG;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; DRUG MECHANISM; HEART INFARCTION; HEART INFARCTION PREVENTION; HEART PROTECTION; HUMAN; MITOCHONDRIAL RESPIRATION; PATHOLOGICAL ANATOMY; PRIORITY JOURNAL; REVIEW;

EID: 0034834240     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/heart.86.4.368     Document Type: Review

References (55)

1. Nitric oxide biology: Implications for cardiovascular therapeutics
2. Turnout necrosis factor and inducible nitric oxide synthase in dilated cardiomyopathy
3. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection
4. Nitric oxide and cardiac function
5. 3, in plasma after experimental myocardial infarction
6. Levels of nitric oxide in the heart after experimental myocardial ischaemia
7. Endothelial NOS expression and ischemia-reperfusion in isolated working rat heart from hypoxic and hyperoxic conditions
8. Basic principles and recent advances
9. Peroxynitrite-induced cardiac myocyte injury
10. Pathological implications of nitric oxide, superoxide and peroxynitrite formation
11. L-arginine limits myocardial cell death secondary to hypoxia-reoxygenation by acGMP-dependent mechanism
12. Myocardial ischemia-reperfusion injury is exaccerbated in the absence of endothelial nitric oxide synthase
13. Cardioprotection and attenuation of endothelial dysfunction by organic nitric oxide donors in myocardial ischemia-reperfusion
14. Cardioprotective effects of authentic nitric oxide in myocardial ischemia with reperfusion
15. Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism
16. Sodium nitroprusside. Exacerbates myocardial ischemia-reperfusion injury
17. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport
18. Nitric oxide protects cultured rat hepatocytes from turnout necrosis factorc-α-induced apoptosis by inducing HSP 70 expression
19. Heme oxygenase-carbon monoxide signalling pathway in atherosclerosis: Antiatherogenic actions of bilirubin and carbon monoxide
20. Nitric oxide: From discovery to the clinic
21. Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury
22. Nitric oxide attenuates cardiac myocyte contraction
23. Nitric oxide-induced cardioprotection in cultured rat ventricular myocytes
24. The nitric oxide hypothesis of late preconditioning
25. Activation of mitochondrial ATP-dependent potassium channels by nitric oxide
26. Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits
27. Hibernation during hypoxia in cardiomyocytes
28. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption
29. Effect of ischaemic preconditioning on myocardial oxygen consumption during ischemia
30. The cell biology of acute myocardial ischaemia
31. Mitochondria as targets for nitric oxide-induced protection during simulated ischemia and reoxygenation in isolated neonatal cardiomyocytes
32. Nitric oxide inhibits dystrophin proteolysis by coxsackieviral protease 2A through N-nitrosylation
33. Nitric oxide: Physiology, pathophysiology, and pharmacology
34. Effect of intravenous nitrates on mortality, in acute myocardial infarction: An overview of the randomised trials
35. ISIS 4: A randomised factorial trial assessing early oral captopril, oral mononitrate and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction
36. GISSI-3: Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6 week mortality and ventricular function after acute myocardial infarction
37. Oral nitrates: More than symptomatic therapy in coronary heart disease?
38. The ESPRIM trial: Short-term treatment of acute myocardial infarction with molsidomine
39. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibitity in humans: Assessment by bicoronary sodium nitroprusside infusion
40. Previous angina alters in-hospital outcome in TIMI 4: A clinical correlate to preconditioning?
41. Effect of the direct nitric oxide donors linsidomine and molsidomine on angiographic restenosis after coronary balloon angioplasty
42. Intravenous nitrates in the prehospital management of acute pulmonary oedema
43. Effect of enalapril, hydralazine plus isosorbide dinitrate and prazosin on hospitalisation in patients with chronic congestive heart failure
44. Diastolic heart failure
45. Supplemental L-arginine during cardioplegic arrest and reperfusion avoids regional postischaemic injury
46. Blood cardioplegia enhanced with nitric oxide donor SPM-5185 counteracts postischemic endothelial and ventricular dysfunction
47. Nitric oxide donors
48. Adenosine preconditioning reduces both pre and postischemic arrhythmias in human myocardium
49. Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure
50. Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions
51. Cardioprotection by opening of the K(ATP) channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. CESAR 2 investigation. Clinical European studies in angina and revascularization
52. Improvement of endothelial function by angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus
53. Nitric oxide mediated venodilator effects of nevibolol
54. Amlodipine promotes kinin-mediated nitric oxide production in coronary microvessels of failing human hearts
55. Effect of amlodipine on morbidity and mortality in severe chronic heart failure